Schedule 13G ownership disclosure

AN2 Therapeutics, Inc.

Common Stock, par value $0.00001 per share · CUSIP: 037326105

Event date: 2024-12-31

Filing-level shares
1,893,132
Percent of class
6.2%
  • Eric Easom

    Shares: 1,893,132 · Class: 6.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-019942
Form type
SCHEDULE 13G/A
Filer
AN2 Therapeutics, Inc.
CIK
CIK 1880438
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub